Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

China: How to keep up and win in the world's fastest changing healthcare market

China: How to keep up and win in the world's fastest changing healthcare market

China's population will start to shrink in 2023 placing greater weight on the working population who have to support increasing numbers of 65+ year olds. The aging population combined with a surge in non-communicable diseases has led to a higher disease burden and more pressure on an already overstretched healthcare system. Seeking to modernise, China has undertaken a range of reforms. 

read more »

Experience conducting research in South East Asia

Experience conducting research in South East Asia

Our emerging markets team has considerable expertise conducting research in South East Asia, with our Asia headquarters located in Singapore, we can support your market research needs. We have conducted over 150 healthcare market research projects across South East Asia covering a wide variety of research objectives and over 25 therapy areas, for both local and international organisations.

read more »

Infographic: Psoriasis (PsO)

Infographic: Psoriasis (PsO)

An overview of the PsO advanced therapy and systemic patient

Our PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot features profile data for patients treated with advanced therapy agents and systemic agents.

read more »

Infographic: Rheumatoid arthritis (RA)

Infographic: Rheumatoid arthritis (RA)

An overview of the RA biologic patient

Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at twelve of the key indices captured in Therapy Watch data.
 
 

read more »

Infographic: HIV

Infographic: HIV

Our latest HIV market snapshot, reveals that 2 in 3 patients are currently treated with an STR (Single-tablet regimen) and more than half are treated with InSTIs (Integrase strand transfer inhibitors). Therapy Watch HIV patient data is collected bi-monthly from a panel of 225 physicians across the main 5 EU markets.

read more »